Feb 22, 2017 Upon Successful Completion of Cohort 3, Cellectar Biosciences Initiates Fourth Cohort of Its Phase I Clinical Trial of CLR 131 in Multiple Myeloma Learn More
Feb 13, 2017 UPDATE -- Cellectar Biosciences to Present at 2017 BIO CEO & Investor Conference Learn More
Jan 31, 2017 Cellectar Biosciences Announces Two Peer Reviewed Studies Demonstrating the Capabilities of the PDC Platform Learn More